PHAR vs GYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

PHAR

58.0
AI Score
VS
GYRE Wins

GYRE

61.0
AI Score

Investment Advisor Scores

PHAR

58score
Recommendation
STRONG BUY

GYRE

61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric PHAR GYRE Winner
Forward P/E 212.766 188.6792 GYRE
PEG Ratio 0 0 Tie
Revenue Growth -3.2% -2.1% GYRE
Earnings Growth -62.9% 166.2% GYRE
Tradestie Score 58.0/100 61.0/100 GYRE
Profit Margin 2.5% -19.3% PHAR
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY BUY PHAR

Relative Price Performance (Last 90 Days)

PHAR 1M: -0.9% · 3M: -15.4% GYRE 1M: -20.8% · 3M: -1.3%

Current Technical Phase

PHAR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.1 · Price: $10.67

GYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 30.8 · Price: $5.86

Fundamentals Snapshot

Metric PHAR GYRE
Market Cap — —
Forward P/E 162.9 -24.9
Trailing P/E 74.2 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.9% 0.9%
Operating Margin 0.0% -0.5%
EPS 0.13 -0.24
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.